Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Best Buy Co Inc (BBY) vs Twist Bioscience Corp (TWST) Price & Performance

Best Buy Co IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Best Buy Co Inc vs Twist Bioscience Corp — how do they compare? Best Buy Co Inc trades at $83.5 (market cap $17.55B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Best Buy Co Inc is far larger — about 2.3× Twist Bioscience Corp's market cap, and Best Buy Co Inc pays a 4.61% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

BBYTWST
Market Cap
$17.55B$7.72B
Sector
Consumer CyclicalHealth
52-Week High
$90.17$124.88
52-Week Low
$55.52$24.16
Enterprise Value
$19.93B$7.65B
Dividend Yield
4.61%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Best Buy Co Inc

With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

Read more on BBY

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST